• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病肾病凝血-纤溶系统的研究——参考血浆凝血酶-抗凝血酶复合物及α2纤溶酶抑制物

[Studies on coagulation-fibrinolytic system in diabetic nephropathy--with reference to plasma TAT and alpha 2PIC].

作者信息

Watanabe S, Ogihara T, Iyori S, Kaneshige H, Nomoto Y, Sakai H

机构信息

Department of Internal Medicine, Hiratsuka City Hospital, Kanagawa, Japan.

出版信息

Nihon Jinzo Gakkai Shi. 1990 Sep;32(9):995-9.

PMID:2148199
Abstract

Coagulation-fibrinolytic system is known to be one of the exacerbating factors in patients with diabetic nephropathy. The aim of the present study was to evaluate whether coagulation-fibrinolytic system in patients with diabetic nephropathy were significantly correlated with the development of this disease using new parameters of plasma thrombin antithrombin III complex (TAT) and plasmin alpha 2 plasmin inhibitor complex (alpha 2PIC). Fifty-six patients with NIDDM were examined. None of these patients showed more than 1.3 mg/dl of serum creatinine levels. These patients were divided into three groups according to the levels of albumin creatinine ratio (ACR) in urine as follows: 1) group I had ACR of less than 30 mg/g.Cr; 2) group II had ACR of greater than 30 mg/g.Cr and less than 100 mg/g.Cr; 3) group III had ACR of greater than 100 mg/g.Cr. Correlations of levels of plasma TAT and alpha 2PIC, levels of HbAlc, duration of diabetes, and presence of retinopathy were determined in these groups. The levels of plasma TAT and alpha 2PIC increased as the levels of urinary ACR increased regardless of presence of retinopathy. The levels of TAT and alpha 2PIC with retinopathy increased compared with those without retinopathy. There was a significantly positive correlation between plasma TAT and alpha 2PIC (r = 0.52, p less than 0.01). The levels of HbAlc and duration of diabetes did not significantly correlate to plasma TAT and alpha 2PIC. These data suggest that the existence of increase in coagulation-fibrinolytic system seem to be one of the exacerbating factors in patients with diabetic nephropathy.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

已知凝血-纤溶系统是糖尿病肾病患者病情加重的因素之一。本研究的目的是使用血浆凝血酶抗凝血酶III复合物(TAT)和纤溶酶α2纤溶酶抑制物复合物(α2PIC)的新参数,评估糖尿病肾病患者的凝血-纤溶系统是否与该疾病的发展显著相关。对56例非胰岛素依赖型糖尿病患者进行了检查。这些患者的血清肌酐水平均未超过1.3mg/dl。根据尿白蛋白肌酐比值(ACR)水平将这些患者分为三组:1)第一组ACR小于30mg/g.Cr;2)第二组ACR大于30mg/g.Cr且小于100mg/g.Cr;3)第三组ACR大于100mg/g.Cr。测定了这些组中血浆TAT和α2PIC水平、糖化血红蛋白(HbAlc)水平、糖尿病病程以及视网膜病变的相关性。无论是否存在视网膜病变,血浆TAT和α2PIC水平均随尿ACR水平升高而升高。有视网膜病变的患者TAT和α2PIC水平高于无视网膜病变的患者。血浆TAT和α2PIC之间存在显著正相关(r = 0.52,p < 0.01)。HbAlc水平和糖尿病病程与血浆TAT和α2PIC无显著相关性。这些数据表明,凝血-纤溶系统的增加似乎是糖尿病肾病患者病情加重的因素之一。(摘要截断于250字)

相似文献

1
[Studies on coagulation-fibrinolytic system in diabetic nephropathy--with reference to plasma TAT and alpha 2PIC].糖尿病肾病凝血-纤溶系统的研究——参考血浆凝血酶-抗凝血酶复合物及α2纤溶酶抑制物
Nihon Jinzo Gakkai Shi. 1990 Sep;32(9):995-9.
2
[Study on coagulation fibrinolytic systems in predialysis patients with chronic renal failure--comparison between patients with chronic glomerulonephritis and patients with diabetic nephropathy].慢性肾衰竭透析前患者凝血纤溶系统的研究——慢性肾小球肾炎患者与糖尿病肾病患者的比较
Nihon Jinzo Gakkai Shi. 1997 Jul;39(5):474-82.
3
Change of lipoprotein (a) and coagulative or fibrinolytic parameters in diabetic patients with nephropathy.糖尿病肾病患者脂蛋白(a)及凝血或纤溶参数的变化
J Atheroscler Thromb. 1994;1(1):37-40. doi: 10.5551/jat1994.1.37.
4
Activation of blood coagulation and fibrinolysis in diabetes mellitus: evaluation by plasma levels of thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex.糖尿病中血液凝固和纤维蛋白溶解的激活:通过血浆凝血酶 - 抗凝血酶III复合物和纤溶酶 - α2 - 纤溶酶抑制剂复合物水平进行评估
Thromb Res. 1989 Sep 15;55(6):727-35. doi: 10.1016/0049-3848(89)90303-4.
5
Low prevalence of coagulation and fibrinolytic activation in patients with primary untreated cancer.原发性未经治疗的癌症患者中凝血和纤溶激活的低发生率
Thromb Haemost. 1990 Nov 30;64(3):361-4.
6
[Plasma levels of antithrombin III, thrombin-antithrombin III complex, alpha 2 plasmin inhibitor and plasmin alpha 2 plasmin inhibitor complex in normal and sick newborn infants].[正常和患病新生儿的抗凝血酶III、凝血酶-抗凝血酶III复合物、α2纤溶酶抑制剂及纤溶酶-α2纤溶酶抑制剂复合物的血浆水平]
Rinsho Ketsueki. 1991 Jul;32(7):758-65.
7
[Clinical application of laboratory diagnosis: leukemia and DIC].[实验室诊断的临床应用:白血病与弥散性血管内凝血]
Rinsho Byori. 1991 Jul;39(7):736-42.
8
[Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].[弥散性血管内凝血(DIC)中的凝血与纤维蛋白溶解参数]
Rinsho Byori. 1991 Mar;39(3):309-14.
9
Circulating thrombomodulin and hematological alterations in type 2 diabetic patients with retinopathy.2型糖尿病视网膜病变患者循环血栓调节蛋白与血液学改变
J Atheroscler Thromb. 1998;5(1):21-8. doi: 10.5551/jat1994.5.21.
10
[Concentration of thrombin antithrombin III complex and plasmin alpha 2-plasmin inhibitor complex in nephrotic syndrome].[肾病综合征中凝血酶 - 抗凝血酶III复合物及纤溶酶α2 - 纤溶酶抑制物复合物的浓度]
Nihon Jinzo Gakkai Shi. 1991 Jul;33(7):653-8.